Company technology platform encompasses
extensive intellectual property which
includes a current total of 10 patents and
patent applications. Four of which are
Chikujee-originated patents with four
patents in-licensed from Avanti
Therapeutics. The Avanti Therapeutics
originated patents are derived from 7 years
of research at bionanotechnology Institute
and cost approximately $ 10 million in
expanded research and development. In
addition, Chikujee plans to submit 4-6
patents in targeted drug delivery within one
year.
